MATINAS BIOPHARMA HOLDINGS, INC. Increase Decrease In Operating Lease Liability
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase Decrease In Operating Lease Liability of -$530.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$365.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$165.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$484.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$195.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2025 was -$1.04M.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2024 was -$655.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2023 was -$562.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2022 was -$520.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$365.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$530.00K 10-Q · filed 2026-08-13 | -$1.01M derived: sum of 3 quarters · filed 2026-08-13 | -$1.21M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$165.00K 10-Q · filed 2026-05-08 | -$649.00K derived: sum of 2 quarters · filed 2026-05-08 | -$844.00K derived: sum of 3 quarters · filed 2026-05-08 | -$1.03M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$679.00K derived: sum of 2 quarters · filed 2026-03-31 | -$863.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.04M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$379.00K derived: sum of 2 quarters · filed 2026-08-13 | -$558.00K 10-Q · filed 2025-11-10 | -$732.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$363.00K 10-Q · filed 2026-08-13 | -$537.00K derived: sum of 3 quarters · filed 2026-08-13 | -$706.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$179.00K 10-Q · filed 2026-05-08 | -$353.00K derived: sum of 2 quarters · filed 2026-05-08 | -$522.00K derived: sum of 3 quarters · filed 2026-05-08 | -$680.00K derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | -$174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$343.00K derived: sum of 2 quarters · filed 2026-03-31 | -$501.00K derived: sum of 3 quarters · filed 2026-03-31 | -$655.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$327.00K derived: sum of 2 quarters · filed 2025-11-10 | -$481.00K 10-Q · filed 2025-11-10 | -$632.00K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$312.00K 10-Q · filed 2025-08-14 | -$463.00K derived: sum of 3 quarters · filed 2025-08-14 | -$608.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$154.00K 10-Q · filed 2025-05-15 | -$305.00K derived: sum of 2 quarters · filed 2025-05-15 | -$450.00K derived: sum of 3 quarters · filed 2025-05-15 | -$584.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$296.00K derived: sum of 2 quarters · filed 2025-04-15 | -$430.00K derived: sum of 3 quarters · filed 2025-04-15 | -$562.00K 10-K · filed 2025-04-15 | ||
| 2023-09-30 | -$145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$279.00K derived: sum of 2 quarters · filed 2024-11-13 | -$411.00K 10-Q · filed 2024-11-13 | -$540.00K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$266.00K 10-Q · filed 2024-08-14 | -$395.00K derived: sum of 3 quarters · filed 2024-08-14 | -$530.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$132.00K 10-Q · filed 2024-05-09 | -$261.00K derived: sum of 2 quarters · filed 2024-05-09 | -$396.00K derived: sum of 3 quarters · filed 2024-05-09 | -$525.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$264.00K derived: sum of 2 quarters · filed 2024-03-27 | -$393.00K derived: sum of 3 quarters · filed 2024-03-27 | -$520.00K 10-K · filed 2024-03-27 | ||
| 2022-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$264.00K derived: sum of 2 quarters · filed 2023-11-08 | -$391.00K 10-Q · filed 2023-11-08 | -$390.94K 10-Q · filed 2022-11-02 | -$515.17K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$256.00K 10-Q · filed 2023-08-09 | -$256.15K 10-Q · filed 2022-08-11 | -$380.17K derived: sum of 3 quarters · filed 2023-08-09 | -$495.18K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$127.00K 10-Q · filed 2023-05-10 | -$251.17K derived: sum of 2 quarters · filed 2023-05-10 | -$366.18K derived: sum of 3 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$124.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$239.18K derived: sum of 2 quarters · filed 2023-03-15 | -$460.00K 10-K · filed 2023-03-15 | |||
| 2021-09-30 | -$115.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$335.83K 10-Q · filed 2022-11-02 | ||||
| 2021-06-30 | -$220.82K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |